Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ratain, Mark J.
One or more keywords matched the following items that are connected to
Ratain, Mark J.
Item Type
Name
Concept
Endpoint Determination
Academic Article
Finding the right dose.
Academic Article
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article
Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST.
Academic Article
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee.
Academic Article
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article
Randomized phase II trials: a long-term investment with promising returns.
Academic Article
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital.
Academic Article
Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.
Academic Article
Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.
Academic Article
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling.
Search Criteria
Endpoint Determination